NCT02970526View on ClinicalTrials.gov

Long Term Effect of Oxaliplatin Treatment in Cancer Survivors

CompletedOBSERVATIONAL
Enrollment

409

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

August 29, 2019

Study Completion Date

August 29, 2019

Conditions
Colorectal Cancer SurvivorsOxaliplatin RegimenAdult
Interventions
DRUG

Oxaliplatin

Intensity of neuropathy induced by oxaliplatin evaluated by the QLQ-CIPN20 Questionnaire (EORTC).

Trial Locations (1)

63003

CHU Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER

NCT02970526 - Long Term Effect of Oxaliplatin Treatment in Cancer Survivors | Biotech Hunter | Biotech Hunter